Published in N Engl J Med on September 09, 1999
Interface between university and medical school: the way ahead? BMJ (2000) 2.40
Medical school faculty discontent: prevalence and predictors of intent to leave academic careers. BMC Med Educ (2007) 2.27
Promotion criteria for clinician-educators. J Gen Intern Med (2003) 2.03
A time to be promoted. The Prospective Study of Promotion in Academia (Prospective Study of Promotion in Academia). J Gen Intern Med (2005) 1.38
Osler, Flexner, apprenticeship and 'the new medical education'. J R Soc Med (2005) 1.38
Hospitalists as teachers. J Gen Intern Med (2004) 1.11
Advantages and challenges of working as a clinician in an academic department of medicine: academic clinicians' perspectives. J Grad Med Educ (2010) 1.11
Predictors of early faculty attrition at one Academic Medical Center. BMC Med Educ (2014) 0.86
Medical students as medical educators: opportunities for skill development in the absence of formal training programs. Yale J Biol Med (2011) 0.85
Promotion for clinician-educators: time for a fresh approach? J Gen Intern Med (2003) 0.81
Mentoring in general surgery in Switzerland. Med Educ Online (2015) 0.78
Examining faculty awards for gender equity and evolving values. J Gen Intern Med (2009) 0.76
Clinician-educators in academic medical centers. N Engl J Med (2000) 0.75
The medical educator teaching portfolio: its compilation and potential utility. Sultan Qaboos Univ Med J (2006) 0.75
Clinician-educators in academic medical centers. N Engl J Med (2000) 0.75
Clinician-educators in academic medical centers. N Engl J Med (2000) 0.75
Who is doing the teaching? J Gen Intern Med (2000) 0.75
Clinician-educators in academic medical centers. N Engl J Med (2000) 0.75
Innovations in education and clinical practice J Gen Intern Med (1999) 0.75
Influences of faculty evaluating system on educational performance of medical school faculty. Korean J Med Educ (2016) 0.75
The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA (1997) 8.30
Haemoglobin A1: An indicator of the metabolic control of diabetic patients. Lancet (1977) 2.48
Effect of improved sanitary facilities on infant diarrhea in a Hopi village. Public Health Rep (1969) 2.20
Isolation and properties of proinsulin, intermediate forms, and other minor components from crystalline bovine insulin. Diabetes (1968) 2.07
A structurally abnormal insulin causing human diabetes. Nature (1979) 1.99
Plexiform neurofibromas in NF1: toward biologic-based therapy. Neurology (2002) 1.90
Somatostatinoma syndrome. Biochemical, morphologic and clinical features. N Engl J Med (1979) 1.88
Integrating clinician-educators into Academic Medical Centers: challenges and potential solutions. Acad Med (2000) 1.57
Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients. Am J Hum Genet (1994) 1.56
Three mutant insulins in man. Nature (1983) 1.40
Fostering a new relationship between departments of medicine and teaching hospitals. Acad Med (1993) 1.39
The limitations to and valid use of C-peptide as a marker of the secretion of insulin. Diabetes (1986) 1.27
Semisynthesis and biological activity of porcine [LeuB24]insulin and [LeuB25]insulin. Proc Natl Acad Sci U S A (1980) 1.16
Neurofibromatosis 2, radiosurgery and malignant nervous system tumours. Br J Cancer (2000) 1.02
The effects of biosynthetic human proinsulin on carbohydrate metabolism. Diabetes (1984) 1.00
Relation of counterregulatory responses to hypoglycemia in type I diabetics. N Engl J Med (1982) 0.96
The detection of contiguous gene deletions at the neurofibromatosis 1 locus with fluorescence in situ hybridization. Cytogenet Cell Genet (1996) 0.96
Glucose kinetics in leprechaunism: accelerated fasting due to insulin resistance. J Clin Endocrinol Metab (1980) 0.91
Concentration and distribution of infectivity and PrPSc following partial denaturation of a mouse-adapted and a hamster-adapted scrapie strain. Arch Virol (1994) 0.88
The selective lipid-lowering effect of vegetarianism on low density lipoproteins in a cross-over experiment. Atherosclerosis (1982) 0.88
Insulin and proinsulin release during calcium infusion in a patient with islet-cell tumor. Metabolism (1975) 0.88
Simultaneous inhibition of insulin and somatomedin-C binding to cultured IM-9 lymphocytes by naturally occurring antireceptor antibodies. Diabetes (1981) 0.86
Evidence for the presence of somatostatin 28 in plasma. Diabetes (1982) 0.86
Lipid values in Kalahari bushmen. Arch Intern Med (1968) 0.85
Plasma lipoprotein abnormalities associated with acquired hepatic triglyceride lipase deficiency. Metabolism (1985) 0.83
Implementation of universal directly observed therapy at a New York City hospital and evaluation of an out-patient directly observed therapy program. Int J Tuberc Lung Dis (1997) 0.82
Insulin-resistant diabetes with insulin receptor autoantibodies in a male patient without acanghosis nigricans. Diabetes Care (1980) 0.80
Parkinsonian syndrome as complication of post-thyroidectomy hypoparathyroidism. N Y State J Med (1974) 0.80
Scrapie strain infection in vitro induces changes in neuronal cells. Mol Neurobiol (1995) 0.80
Taste detection and preferences in diabetics and their relatives. Psychosom Med (1979) 0.79
Activism in academic internal medicine. Ann Intern Med (1992) 0.79
Biosynthetic human insulin and proinsulin have additive but not synergistic effects on total body glucose disposal. J Clin Endocrinol Metab (1984) 0.79
C-peptide analysis in diagnosis of factitial hypoglycemia in an insulin-dependent diabetic. Mayo Clin Proc (1975) 0.79
Striatal tachykinin gene expression regulated by interaction of D-1 and D-2 dopamine receptors. J Pharmacol Exp Ther (1989) 0.78
The management of Shy-Drager syndrome with propantheline and intermittent self-catheterization: a case report. J Urol (1981) 0.78
Endocrine-metabolic relationships in patients with leprechaunism. J Natl Med Assoc (1982) 0.78
Acute effect of ascorbic acid infusion on carbohydrate tolerance. Am J Clin Nutr (1976) 0.77
Seventh-Day Adventist adolescents--life-style patterns and cardiovascular risk factors. West J Med (1984) 0.75
Primary central nervous system lymphoma in a pediatric patient with acquired immune deficiency syndrome. Treatment with radiation therapy. Cancer (1990) 0.75
Pseudo-Terson's syndrome: bilateral simultaneous rhegmatogenous retinal detachment. Eye (Lond) (2004) 0.75
Cutaneous manifestations of leprechaunism. Arch Dermatol (1981) 0.75
The effects of tolbutamide on the development of atherosclerosis in rhesus monkeys fed an average American table-prepared diet. Adv Exp Med Biol (1975) 0.75
Medical complications of isotretinoin. Clin Dermatol (1990) 0.75
Characteristics of binding of a low affinity, noncooperative insulin [( LeuB25]insulin) to IM-9 lymphocytes. Endocrinology (1983) 0.75
Diabetes and pregnancy. J Reprod Med (1973) 0.75
Hepatic ultrastructure in leprechaunism. Hepatic ultrastructural evidence suggesting a syndrome with defective hepatic glucose release. Virchows Arch A Pathol Anat Histol (1982) 0.75
Internalization and degradation of a low affinity insulin ([LeuB24]insulin) by rat adipocytes. FEBS Lett (1982) 0.75
Far beyond informed consent. US research institutions keep close watch on OPRR's suspensions. J Investig Med (1999) 0.75
Response of rhesus serum high density lipoproteins to cycles of diet-induced hypercholesterolemia. Arteriosclerosis (1984) 0.75
Eustachian tube bypass. IMJ Ill Med J (1984) 0.75